演題
ポスター発表: 演題一覧

ポスター番号(PosterID*)は、研究分野毎の新しい番号がつけられています。

Pn: n = 研究分野番号(1〜7)
1: 分子計算 (Molecular Computing)
2: 分子認識 (Molecular Recognition)
3: 分子生物学における情報計算技術
(Bioinformatics and Bio Computing)
4: ゲノムワイドな実験データの解析
(Genome Wide Experimental Data Analyses)
5: 医薬品研究と毒性研究支援システム
(Information and Computing Infrastructure for Drug Design and Toxicology)
6: 疾病メカニズムと制御モデル
(Disease Mechanism and Control Model)
7: ゲノム医療情報と新技術
(Medical Genome Informatics and New Technology)
PosterID* Title Original ID
P1-01 Crystal structure and molecular dynamics simulation of ST0689 from Sulfolobus tokodaii strain7 4
P1-02 Alkylation Mechanism of BPDE with DNA by Quantum Molecular Dynamics Simulation. 13
P1-03 Enantioselectivity of Candida antarctica Lipase TypeB toward Secondary Alcohols: Ab initio Fragment Molecular Orbital Study 27
P1-04 The Low-Frequency Raman Modes of Crystals of Guanosine Dihydrate Analyzed from MD Simulation 48
P1-05 Intra- and intermolecular interactions between cyclic-AMP receptor protein and DNA: Ab initio fragment molecular orbital study 49
P1-06 Development of virtual screening method using Solvation Free Energy Density Model(SFED) 52
P1-07 Computational Study of Catalytic Reaction of Adenylate Kinase 65
P1-08 NFV-Resistant Mechanism due to Non-active Site Mutation N88S on Subtype AE HIV-1 PRs 66
P1-09 Evaluation of the binding affinity of antibodies from antigen binding energy and VH-VL interaction energy calculated by the MM-GBSA method 67
P1-10 Prediction of complex structure comprised of a protein and a glycosaminoglycan using docking simulation and cluster analysis 68
P1-11 Catalytic reaction of the enzyme degrading biodegradable plastics 69
P2-01 In silico drug screening by docking score index method using principal component analysis 2
P2-02 Solvent Site-Dipole Field Mediating Docking of Biomolecules 14
P2-03 Application of Amino Acid Descriptors for Prediction of MHC-peptide binding affinity 19
P2-04 Molecular modeling and 3D-QSAR studies of benzothiazol-2-ylacetonitrile derivatives as c-Jun N-terminal kinase 3 inhibitors 21
P2-05 Bootstrap-based consensus scoring method for high-performance and robust drug screening by single scoring function 22
P2-06 introduction of initial binding orientation in protein- protein docking 41
P2-07 Functions of the key residues in the ligand-binding pocket of vitamin D receptor: Fragment molecular orbital-interfragment interaction energy analysis 57
P2-08 A Workbench for Selective Nuclear Receptor Modulators 72
P3-01 Discrimination of beta-barrel Membrane Proteins: Comparison between Statistical Methods and Machine Learning Algorithms 1
P3-02 SPLITS: an Expanding Program for Split and Intron-Containing tRNA Prediction 10
P3-03 Phylogenetic profiling approach to generate RNA-protein networks in E. coli 12
P3-04 Development and application of a molecular dynamics simulation system : myPresto 15
P3-05 Automatic Procaryote ORF Finding by Markov Model 23
P3-06 Prediction of nuclear localization proteins based on charge periodicity of 28 residues 24
P3-07 WinBEST-KIT (Biochemical Reaction Simulator for Analyzing Metabolic Pathways): Application to the System Analysis of Acetone-Butanol-Ethnol Fermentation in Clostridium saccharoperbutylacetonicum 28
P3-08 An Integrated Database of Flavonoids 30
P3-09 Estimation of Gene Regulatory Network by means of AdaBoost 31
P3-10 Theoretical studies of the ATP hydrolysis mechanism of HisP protein 36
P3-11 Proteins with charge periodicity of 28 residues which are coded in total genomes 37
P3-12 Systematic Errors Commonly Found in GeneChip Expression Data and Effective Compensation Methods thereof 40
P3-13 Protein functional site prediction -DNA binding protein- 46
P3-14 HP-Lattice-model Structure Prediction of Proteins 50
P3-15 Prediction of Human Cytochrome P450 3A4 Substrates using Statistical analysis 53
P3-16 Branch And Bound Median Search algorithm for finding a substrate specific motif at human SLC22 transporters 58
P3-17 A Molecular Modeling Study on Antigenic Drifts of Influenza Virus Surface Glycoprotein 59
P3-18 Analysis of amino acid sequences of motor protein by physical finger print method 62
P3-19 A New Method for Analysis of SNP’s Effect on Protein Function and Structure 64
P3-20 Application of Connectivity Matrix Method to Atom-level Analysis of Metabolic Networks: Calculation of Paths Connecting Two Metabolites 70
P4-01 Microarray analysis based on Standard Deviation of Effecting of Biological Factors 5
P4-02 Detecting Cell Cycle Regulated genes in S. pombe with Non-metric Multidimensional Scaling without sinusoidal fittings 11
P4-03 Comprehensive analyses on relationships between alternative-splicing patterns and developmental stages in mouse 33
P4-04 Genome-wide Prediction of Novel Small Peptides in Escherichia coli by Using Liquid Chromatography Mass Spectrometry 34
P4-05 Transcriptomic approach for understanding the effect of cryoprotectant, trehalose and DMSO of Saccharomyces cerevisiae 44
P4-06 GC contents of nucleotide sequences for proteins with charge periodicity of 28 residues 51
P5-01 PBPK-modeling as a tool for interpreting and understanding of pharmacokinetics 3
P5-02 Scaffold analysis of GPCR ligand datasets from literature. 6
P5-03 Development of New in silico Method for Predicting Drug Metabolism 7
P5-04 “CALTA”, a novel structure-property-activity profiling method: Compound-scaffold profiling and in silico prediction for the drug-discovery compounds that target membrane proteins 8
P5-05 Virtual Screening Models for Predicting Activities in Various Therapeutic Areas 9
P5-06 Convergence properties of absolute binding free energy calculation using BAR method 16
P5-07 Building up an original database of launched drugs for their ADME and physicochemical HTS profiling data and human PK data. 17
P5-08 Conceptual Design of a Framework for ADME Ontology 18
P5-09 Acquisition of Extended Information Regarding Chemicals-CYPs Interactions by Natural Language Processing 25
P5-10 Ontology Development for RTK-Associated Information Retrieval System 26
P5-11 Physiologically Based Pharmacokinetic (PBPK) model for pravastatin - Analysis of transporter-related pharmacokinetics - 29
P5-12 A Web-Based Drug Safety Information Community 35
P5-13 Instant Computing Technology for Molecular Design Environment for Non-Cluster Experts 38
P5-14 Conformational Analysis and Docking Study of the c-Jun N-Terminal Kinase Inhibitors Having a Benzothiazol Moiety 42
P5-15 Development of an Empirical Model for the Activation Energy of CYP Reaction 43
P5-16 Prediction of Skin Permeability for Chemical Penetration Enhnacers using Quantitative Structure Activity Relationship Analysis and Classification methodology 54
P5-17 In Silico Prediction of CYP1A2-mediated Metabolism 55
P5-18 Classification of P-Glycoprotein Substrates and Inhibitors 56
P5-19 NMR metabolomics 1/2 Multivariate analysis for diagnostic study of inherited metabolic disorders using human urine 60
P5-20 NMR metabolomics 2/2;Multivariate analysis for diagnostic study of streptozotocin-induced diabetes using rat urine 61
P5-21 Development of a database with simulation function for quantitative prediction of drug-drug interactions 63
P5-22 In vitro screening system using a combination of suspensions and monolayers of Caco-2 cells for detecting drug-drug interactions in intestinal absorption and conjugative metabolism of drugs 73
P5-23 Transport and metabolism of ampicillin prodrugs and their interactions with P-glycoprotein: in vitro study on successful prodrugs using Caco-2 cell monolayers 74
P6-01 Mathematical modeling of gene expression associated with Wnt signaling pathway in colorectal carcinoma 32
P6-02 Modeling of extracellular matrix degradation processes in cancer metastasis using covariance structure analysis 39
P6-03 Comprehensive analysis of drug-specific mutation patterns in protease gene of HIV-1 subtype B using decision tree 47
P7-01 Tutorial and Training Courses on Some Areas of Interest of the CBI Society 71